DexCom Return on Tangible Equity 2010-2025 | DXCM
Current and historical return on tangible equity values for DexCom (DXCM) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| DexCom Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $0.57B | $2.46B | 27.13% |
| 2025-03-31 | $0.54B | $2.15B | 25.93% |
| 2024-12-31 | $0.58B | $1.98B | 28.07% |
| 2024-09-30 | $0.68B | $1.85B | 33.40% |
| 2024-06-30 | $0.67B | $2.30B | 31.75% |
| 2024-03-31 | $0.64B | $2.10B | 31.84% |
| 2023-12-31 | $0.54B | $1.91B | 27.20% |
| 2023-09-30 | $0.38B | $2.10B | 18.91% |
| 2023-06-30 | $0.36B | $1.92B | 18.67% |
| 2023-03-31 | $0.29B | $2.04B | 14.73% |
| 2022-12-31 | $0.34B | $1.93B | 16.96% |
| 2022-09-30 | $0.24B | $1.78B | 12.06% |
| 2022-06-30 | $0.23B | $2.20B | 10.91% |
| 2022-03-31 | $0.26B | $2.13B | 12.53% |
| 2021-12-31 | $0.22B | $1.98B | 10.91% |
| 2021-09-30 | $0.63B | $2.11B | 32.62% |
| 2021-06-30 | $0.62B | $1.98B | 34.68% |
| 2021-03-31 | $0.59B | $1.88B | 36.14% |
| 2020-12-31 | $0.55B | $1.79B | 39.80% |
| 2020-09-30 | $0.23B | $1.48B | 20.11% |
| 2020-06-30 | $0.21B | $1.34B | 21.24% |
| 2020-03-31 | $0.15B | $0.92B | 18.52% |
| 2019-12-31 | $0.10B | $0.86B | 13.79% |
| 2019-09-30 | $-0.17B | $0.75B | -25.38% |
| 2019-06-30 | $-0.17B | $0.67B | -27.26% |
| 2019-03-31 | $-0.13B | $0.65B | -22.52% |
| 2018-12-31 | $-0.13B | $0.65B | -24.56% |
| 2018-09-30 | $0.04B | $0.54B | 9.62% |
| 2018-06-30 | $-0.01B | $0.47B | -1.21% |
| 2018-03-31 | $-0.03B | $0.41B | -8.37% |
| 2017-12-31 | $-0.05B | $0.41B | -14.42% |
| 2017-09-30 | $-0.05B | $0.37B | -15.32% |
| 2017-06-30 | $-0.07B | $0.34B | -23.03% |
| 2017-03-31 | $-0.09B | $0.27B | -34.51% |
| 2016-12-31 | $-0.07B | $0.27B | -26.53% |
| 2016-09-30 | $-0.06B | $0.25B | -24.30% |
| 2016-06-30 | $-0.08B | $0.23B | -37.17% |
| 2016-03-31 | $-0.06B | $0.23B | -32.28% |
| 2015-12-31 | $-0.06B | $0.22B | -32.68% |
| 2015-09-30 | $-0.06B | $0.19B | -37.52% |
| 2015-06-30 | $-0.02B | $0.17B | -15.25% |
| 2015-03-31 | $-0.02B | $0.14B | -19.21% |
| 2014-12-31 | $-0.02B | $0.13B | -21.96% |
| 2014-09-30 | $-0.03B | $0.11B | -29.83% |
| 2014-06-30 | $-0.03B | $0.09B | -34.89% |
| 2014-03-31 | $-0.03B | $0.08B | -43.69% |
| 2013-12-31 | $-0.03B | $0.08B | -43.48% |
| 2013-09-30 | $-0.04B | $0.07B | -52.04% |
| 2013-06-30 | $-0.05B | $0.07B | -67.15% |
| 2013-03-31 | $-0.05B | $0.07B | -69.62% |
| 2012-12-31 | $-0.05B | $0.07B | -67.71% |
| 2012-09-30 | $-0.06B | $0.07B | -65.54% |
| 2012-06-30 | $-0.05B | $0.08B | -54.82% |
| 2012-03-31 | $-0.05B | $0.09B | -42.59% |
| 2011-12-31 | $-0.04B | $0.11B | -44.78% |
| 2011-09-30 | $-0.04B | $0.11B | -48.14% |
| 2011-06-30 | $-0.04B | $0.12B | -61.99% |
| 2011-03-31 | $-0.05B | $0.05B | -98.95% |
| 2010-12-31 | $-0.06B | $0.06B | -119.57% |
| 2010-09-30 | $-0.06B | $0.04B | -217.14% |
| 2010-06-30 | $-0.06B | $0.04B | -380.33% |
| 2010-03-31 | $-0.06B | $0.05B | -1109.09% |
| 2009-12-31 | $-0.05B | $-0.02B | 2160.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $30.925B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $173.973B | 21.05 |
| Intuitive Surgical (ISRG) | United States | $168.513B | 69.85 |
| IDEXX Laboratories (IDXX) | United States | $52.648B | 54.79 |
| Edwards Lifesciences (EW) | United States | $45.999B | 30.49 |
| Alcon (ALC) | Switzerland | $42.296B | 28.58 |
| IQVIA Holdings (IQV) | United States | $30.576B | 17.28 |
| Mettler-Toledo (MTD) | United States | $25.872B | 30.71 |
| STERIS (STE) | Ireland | $23.889B | 25.46 |
| Waters (WAT) | United States | $16.738B | 22.99 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.603B | 0.00 |
| Hologic (HOLX) | United States | $15.138B | 16.40 |
| Penumbra (PEN) | United States | $9.379B | 68.52 |
| Sysmex ADR (SSMXY) | Japan | $8.712B | 27.68 |
| Globus Medical (GMED) | United States | $7.940B | 18.27 |
| Masimo (MASI) | United States | $7.862B | 26.46 |
| Teleflex (TFX) | United States | $5.233B | 8.45 |
| Glaukos (GKOS) | United States | $4.855B | 0.00 |
| TransMedics (TMDX) | United States | $3.903B | 59.33 |
| Integer Holdings (ITGR) | United States | $3.729B | 18.61 |
| LivaNova (LIVN) | United Kingdom | $2.667B | 15.26 |
| Alphatec Holdings (ATEC) | United States | $2.215B | 0.00 |
| Veracyte (VCYT) | United States | $2.143B | 29.75 |
| PROCEPT BioRobotics (PRCT) | United States | $2.125B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.981B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.881B | 16.91 |
| Artivion (AORT) | United States | $1.749B | 97.50 |
| Integra LifeSciences Holdings (IART) | United States | $1.010B | 5.79 |
| OPKO Health (OPK) | United States | $0.992B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| IRadimed (IRMD) | United States | $0.890B | 43.17 |
| Tandem Diabetes Care (TNDM) | United States | $0.759B | 0.00 |
| SiBone (SIBN) | United States | $0.676B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.641B | 0.00 |
| AxoGen (AXGN) | United States | $0.640B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.535B | 4.30 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.502B | 8.87 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.490B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.474B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.386B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.354B | 8.99 |
| Delcath Systems (DCTH) | United States | $0.350B | 83.42 |
| AngioDynamics (ANGO) | United States | $0.346B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.303B | 0.00 |
| NeuroPace (NPCE) | United States | $0.295B | 0.00 |
| RxSight (RXST) | United States | $0.292B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.288B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.274B | 18.89 |
| Neuronetics (STIM) | United States | $0.273B | 0.00 |
| 908 Devices (MASS) | United States | $0.227B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.219B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.193B | 0.00 |
| CVRx (CVRX) | United States | $0.189B | 0.00 |
| Inogen (INGN) | United States | $0.174B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.169B | 0.00 |
| Accuray (ARAY) | United States | $0.157B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.149B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.117B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.112B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.089B | 0.00 |
| Spectral AI (MDAI) | United States | $0.062B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.047B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.74 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |